uniQure (QURE) Interest Coverage Ratio Growth (3y) (2019 - 2026)
uniQure (QURE) Interest Coverage Ratio Growth (3y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
29.25% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-16.86% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
uniQure |
2.88 Bn |
2.88 Bn |
3.34 Mn |
46.11% |
| Date | Value |
|---|
| Mar 31, 2026 |
46.11% |
| Dec 31, 2025 |
-9.22% |
| Sep 30, 2025 |
46.01% |
| Jun 30, 2025 |
48.68% |
| Mar 31, 2025 |
50.53% |
| Dec 31, 2024 |
69.39% |
| Sep 30, 2024 |
53.04% |
| Jun 30, 2024 |
-26.26% |
| Mar 31, 2024 |
51.02% |
| Dec 31, 2023 |
44.64% |
| Sep 30, 2023 |
51.76% |
| Jun 30, 2023 |
37.72% |
| Mar 31, 2023 |
16.17% |
| Dec 31, 2022 |
-49.40% |
| Sep 30, 2022 |
15.92% |
| Jun 30, 2022 |
12.72% |
| Mar 31, 2022 |
9.22% |
| Dec 31, 2021 |
-53.96% |
| Sep 30, 2021 |
19.65% |
| Jun 30, 2021 |
96.40% |
